BTIG analyst Janine Stichter adjusted the price target for Steven Madden (NASDAQ: NASDAQ:SHOO) shares to $46.00, down from ...

BTIG lowered the firm’s price target on Steven Madden (SHOO) to $46 from $52 and keeps a Buy rating on the shares after meeting with its ...

BTIG analyst Clark Lampen adjusted the price target for Roblox Corp . (NYSE:RBLX) shares, raising it to $73 from the previous $66, while maintaining a Buy rating on the stock. The reevaluation ...

BTIG raised the firm’s price target on Roblox (RBLX) to $73 from $66 and keeps a Buy rating on the shares. Q4 results missed the firm’s ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...

BTIG Research lowered shares of IQVIA (NYSE:IQV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat.com reports. Several other ...

Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently ...